Cargando…

Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users

BACKGROUND: Hypertension is a common complication in injection drug users (IDU), especially a high proportion of resistant hypertension occurs among them. However, the involving mechanisms remain largely unknown. METHODS: We here investigated the key signaling moieties in resistant hypertension in d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Jie, Yang, Ji-Qun, Du, Ying-Rong, Xu, Yu, Kong, Deshenyue, Zhang, Xiu-Ling, Mao, Jun-Hong, Hu, Gui-Fang, Wang, Kun-Hua, Kuang, Yi-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191201/
https://www.ncbi.nlm.nih.gov/pubmed/35706529
http://dx.doi.org/10.2147/JIR.S361634
_version_ 1784725962362978304
author Jia, Jie
Yang, Ji-Qun
Du, Ying-Rong
Xu, Yu
Kong, Deshenyue
Zhang, Xiu-Ling
Mao, Jun-Hong
Hu, Gui-Fang
Wang, Kun-Hua
Kuang, Yi-Qun
author_facet Jia, Jie
Yang, Ji-Qun
Du, Ying-Rong
Xu, Yu
Kong, Deshenyue
Zhang, Xiu-Ling
Mao, Jun-Hong
Hu, Gui-Fang
Wang, Kun-Hua
Kuang, Yi-Qun
author_sort Jia, Jie
collection PubMed
description BACKGROUND: Hypertension is a common complication in injection drug users (IDU), especially a high proportion of resistant hypertension occurs among them. However, the involving mechanisms remain largely unknown. METHODS: We here investigated the key signaling moieties in resistant hypertension in drug users. Analyses were performed with high-throughput transcriptomic sequencing data of peripheral blood from individuals with drug-sensitive hypertension (Ctrl-DS), IDU with resistant hypertension (IDU-DR), and IDU with sensitive hypertension (IDU-DS). RESULTS: We showed that 17 and 1 genes in IDU-DS, 48 and 4 genes in IDU-DR were upregulated and downregulated compared Ctrl-DS, and 2 and 4 genes were upregulated and downregulated in IDU-DR compared with IDU-DS, respectively (p ≤ 0.01 and |log(2)(FC)| ≥ 1). Differentially expressed genes (DEGs) between Ctrl-DS and IDU-DS were mainly involved in Gene ontology terms of immunoglobulin complex and blood microparticle. DEGs between IDU-DS and IDU-DR were mainly involved in immune system process and immunoglobulin complex. DEGs between Ctrl-DS and IDU-DR were mainly involved in immunoglobulin complex, blood microparticle and cytoplasmic vesicle lumen. We identified 2 gene clusters (brown modules, MEbrown; turquoise module, MEturquoise) correlated with IDU-DR and a gene cluster (magenta module, MEmagenta) correlated with IDU-DS by weighted gene co-expression network analysis (WGCNA). Functional analysis demonstrated that pathways of focal adhesion and focalin-1-rich granule lumen were involved in the development of IDU-DR, and the cytosolic large ribosomal subunit may relate to IDU-DR. Further, immune cell infiltration analysis demonstrated that the abundance of dendritic cells (DCs), natural Treg cells (nTreg), and exhausted T cells (Tex) in IDU-DR and IDU-DS, naïve CD8(+) T cells in IDU-DS was significantly different compared with that in Ctrl-DS. The abundance of cytotoxic T cells (Tc) was significantly different between IDU-DS and IDU-DR. CONCLUSION: Our findings indicated a potential function of immunoregulation mechanisms for resistant hypertension.
format Online
Article
Text
id pubmed-9191201
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91912012022-06-14 Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users Jia, Jie Yang, Ji-Qun Du, Ying-Rong Xu, Yu Kong, Deshenyue Zhang, Xiu-Ling Mao, Jun-Hong Hu, Gui-Fang Wang, Kun-Hua Kuang, Yi-Qun J Inflamm Res Original Research BACKGROUND: Hypertension is a common complication in injection drug users (IDU), especially a high proportion of resistant hypertension occurs among them. However, the involving mechanisms remain largely unknown. METHODS: We here investigated the key signaling moieties in resistant hypertension in drug users. Analyses were performed with high-throughput transcriptomic sequencing data of peripheral blood from individuals with drug-sensitive hypertension (Ctrl-DS), IDU with resistant hypertension (IDU-DR), and IDU with sensitive hypertension (IDU-DS). RESULTS: We showed that 17 and 1 genes in IDU-DS, 48 and 4 genes in IDU-DR were upregulated and downregulated compared Ctrl-DS, and 2 and 4 genes were upregulated and downregulated in IDU-DR compared with IDU-DS, respectively (p ≤ 0.01 and |log(2)(FC)| ≥ 1). Differentially expressed genes (DEGs) between Ctrl-DS and IDU-DS were mainly involved in Gene ontology terms of immunoglobulin complex and blood microparticle. DEGs between IDU-DS and IDU-DR were mainly involved in immune system process and immunoglobulin complex. DEGs between Ctrl-DS and IDU-DR were mainly involved in immunoglobulin complex, blood microparticle and cytoplasmic vesicle lumen. We identified 2 gene clusters (brown modules, MEbrown; turquoise module, MEturquoise) correlated with IDU-DR and a gene cluster (magenta module, MEmagenta) correlated with IDU-DS by weighted gene co-expression network analysis (WGCNA). Functional analysis demonstrated that pathways of focal adhesion and focalin-1-rich granule lumen were involved in the development of IDU-DR, and the cytosolic large ribosomal subunit may relate to IDU-DR. Further, immune cell infiltration analysis demonstrated that the abundance of dendritic cells (DCs), natural Treg cells (nTreg), and exhausted T cells (Tex) in IDU-DR and IDU-DS, naïve CD8(+) T cells in IDU-DS was significantly different compared with that in Ctrl-DS. The abundance of cytotoxic T cells (Tc) was significantly different between IDU-DS and IDU-DR. CONCLUSION: Our findings indicated a potential function of immunoregulation mechanisms for resistant hypertension. Dove 2022-06-09 /pmc/articles/PMC9191201/ /pubmed/35706529 http://dx.doi.org/10.2147/JIR.S361634 Text en © 2022 Jia et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jia, Jie
Yang, Ji-Qun
Du, Ying-Rong
Xu, Yu
Kong, Deshenyue
Zhang, Xiu-Ling
Mao, Jun-Hong
Hu, Gui-Fang
Wang, Kun-Hua
Kuang, Yi-Qun
Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users
title Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users
title_full Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users
title_fullStr Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users
title_full_unstemmed Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users
title_short Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users
title_sort transcriptomic profiling reveals underlying immunoregulation mechanisms of resistant hypertension in injection drug users
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191201/
https://www.ncbi.nlm.nih.gov/pubmed/35706529
http://dx.doi.org/10.2147/JIR.S361634
work_keys_str_mv AT jiajie transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT yangjiqun transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT duyingrong transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT xuyu transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT kongdeshenyue transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT zhangxiuling transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT maojunhong transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT huguifang transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT wangkunhua transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers
AT kuangyiqun transcriptomicprofilingrevealsunderlyingimmunoregulationmechanismsofresistanthypertensionininjectiondrugusers